MiMedx Group, Inc. (MDXG)
4.54
+0.04
(+0.89%)
USD |
NASDAQ |
Aug 31, 16:00
4.545
0.00 (0.00%)
After-Hours: 20:00
MiMedx Group Total Long Term Debt (Quarterly) : 17.21M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 17.21M |
| March 31, 2026 | 17.59M |
| December 31, 2025 | 21.21M |
| September 30, 2025 | 18.21M |
| June 30, 2025 | 18.46M |
| March 31, 2025 | 18.66M |
| December 31, 2024 | 23.54M |
| September 30, 2024 | 19.02M |
| June 30, 2024 | 19.25M |
| March 31, 2024 | 19.45M |
| December 31, 2023 | 49.05M |
| September 30, 2023 | 48.97M |
| June 30, 2023 | 48.84M |
| March 31, 2023 | 48.71M |
| December 31, 2022 | 51.08M |
| September 30, 2022 | 48.48M |
| June 30, 2022 | 48.36M |
| March 31, 2022 | 48.24M |
| December 31, 2021 | 52.09M |
| September 30, 2021 | 48.02M |
| June 30, 2021 | 47.90M |
| March 31, 2021 | 50.44M |
| December 31, 2020 | 50.66M |
| September 30, 2020 | 48.03M |
| June 30, 2020 | 67.52M |
| Date | Value |
|---|---|
| March 31, 2020 | 68.00M |
| December 31, 2019 | 68.58M |
| September 30, 2019 | 69.14M |
| June 30, 2019 | 66.82M |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.229M |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.286M |
| September 30, 2017 | 0.0086M |
| June 30, 2017 | 0.015M |
| March 31, 2017 | 0.021M |
| December 31, 2016 | 0.031M |
| September 30, 2016 | 0.041M |
| June 30, 2016 | 0.072M |
| March 31, 2016 | 0.103M |
| December 31, 2015 | 0.133M |
| September 30, 2015 | 0.163M |
| June 30, 2015 | 0.192M |
| March 31, 2015 | 0.221M |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.2777M |
| June 30, 2014 | 0.3055M |
| March 31, 2014 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | 23.32M |
| Perspective Therapeutics, Inc. | 2.866M |
| ABVC BioPharma, Inc. | 1.406M |
| Enovis Corp. | 1.344B |
| Edwards Lifesciences Corp. | 680.30M |